Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid users. [electronic resource]
- Journal of clinical pharmacology 12 2015
- 1351-61 p. digital